Efficacy and safety of 'true' cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: A systematic review and meta-analysis

Diabetic Medicine

Volumn 29, Issue 12, 2012, Pages 1480-1492

  Ranasinghe, P ^a   Jayawardana, R ^a,b   Galappaththy, P ^a   Constantine, G R ^a   de Vas Gunawardana, N ^a,c   Katulanda, P ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c MINISTRY OF HEALTH   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; AMYLASE; ANTIDIABETIC AGENT; CINNAMALDEHYDE; CINNAMOMUM ZEYLANICUM EXTRACT; CINNAMON EXTRACT; CINNAMON OIL; CINNAMTANNIN B1; FLUOXETINE; GLIBENCLAMIDE; GLIPIZIDE; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCOGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN RECEPTOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROANTHOCYANIDIN; SUCRASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VEGETABLE OIL;

ALLOXAN DIABETES MELLITUS; CARBOHYDRATE METABOLISM; CELL MEMBRANE; CINAHL; CINNAMOMUM CASSIA; CINNAMOMUM ZEYLANICUM; COCHRANE LIBRARY; CONCENTRATION RESPONSE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIET RESTRICTION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; GLUCONEOGENESIS; GLUCOSE ABSORPTION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INTESTINE ABSORPTION; KIDNEY FUNCTION; LD 50; LIVER FUNCTION; LOW DRUG DOSE; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; NONHUMAN; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; SYSTEMATIC REVIEW; TOXICITY TESTING; WEIGHT REDUCTION;

ANIMALS; CINNAMOMUM ZEYLANICUM; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR;

EID: 84869138749     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03718.x     Document Type: Review

References (57)

1. World Health Organization. WHO Diabetes Fact Sheet. 2011 [22/08/2011]; Available at http://www.who.int/mediacentre/factsheets/fs312/en/index.html Last accessed 22 August 2011.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
3. International Diabetes Federation. IDF Diabetes Atlas - The Economic Impacts of Diabetes. 2010. Available at http://www.diabetesatlas.com/content/economic-impacts-diabetes Last accessed 22 August 2011.
4. Levin M, Pfeifer M. Uncomplicated Guide To Diabetes Complications, 3 edn. Alexandria: American Diabetes Association, 2009.
5. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005; 365: 1333-1346.
6. Sutherland JE, Hoehns JD. Treating type 2 diabetes: targeting the many causative factors. J Fam Pract 2004; 53: 376-388.
7. Centers for Disease Control and Prevention, eds. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
8. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27: 1218-1224.
9. Alvarez Guisasola F, Tofe Povedano S, Krishnarajah G, Lyu R, Mavros P, Yin D. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obes Metab 2008; 10(Suppl 1): 25-32.
10. Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ 2007; 33: 1014-1029.
11. Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care 2003; 26: 1408-1412.
12. Bailey CJ, Kodack M. Patient adherence to medication requirements for therapy of Type 2 diabetes. Int J Clin Pract 2011; 65: 314-322.
13. Dham S, Shah V, Hirsch S, Banerji MA. The role of complementary and alternative medicine in diabetes. Curr Diab Rep 2006; 6: 251-258.
14. Bodeker G, Kronenberg F. A public health agenda for traditional, complementary, and alternative medicine. Am J Public Health 2002; 92: 1582-1591.
15. Bell RA, Suerken CK, Grzywacz JG, Lang W, Quandt SA, Arcury TA. Complementary and alternative medicine use among adults with diabetes in the United States. Altern Ther Health Med 2006; 12: 16-22.
16. Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008; 31(Suppl 1): S61-S78.
17. Samad A, Shams MS, Ullah Z, Wais M, Nazish I, Sultana Y et al. Status of herbal medicines in the treatment of diabetes: a review. Curr Diabetes Rev 2009; 5: 102-111.
18. Jayaprakasha G, Jagan Mohan Rao L. Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum. Crit Rev Food Sci Nutr 2011; 51: 547-562.
19. Ouattara B, Simard RE, Holley RA, Piette GJ, Begin A. Antibacterial activity of selected fatty acids and essential oils against six meat spoilage organisms. Int J Food Microbiol 1997; 37: 155-162.
20. Gruenwald J, Freder J, Armbruester N. Cinnamon and health. Crit Rev Food Sci Nutr 2010; 50: 822-834.
21. Cao H, Polansky MM, Anderson RA. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys 2007; 459: 214-222.
22. Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res Clin Pract 2003; 62: 139-148.
23. Baker WL, Gutierrez-Williams G, White CM, Kluger J, Coleman CI. Effect of cinnamon on glucose control and lipid parameters. Diabetes Care 2008; 31: 41-43.
24. Archer A. Determination of cinnamaldehyde, coumarin and cinnamyl alcohol in cinnamon and cassia by high-performance liquid chromatography. J Chromatogr 1988; 447: 272-276.
25. Abraham K, Wohrlin F, Lindtner O, Heinemeyer G, Lampen A. Toxicology and risk assessment of coumarin: focus on human data. Mol Nutr Food Res 2010; 54: 228-239.
26. European Food Safety Association. Coumarin in flavourings and other food ingredients with flavouring properties. EFSA J 2008; 793: 1-15.
27. The PRISMA GroupMoher D, Liberati A, Tetzlaff J, Altman DG, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
28. Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 101-129.
29. Higgins IP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
30. Al-Logmani AS, Zari TA. Effects of Nigella sativa L. and Cinnamomum zeylanicum Blume oils on some physiological parameters in streptozotocin-induced diabetic rats. Bol Latinoam Caribe Plantas M 2009; 8: 86-96.
31. Anand P, Murali KY, Tandon V, Murthy PS, Chandra R. Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats. Chemico-Biolog Interact 2010; 186: 72-81.
32. Gumy C, Thurnbichler C, Aubry EM, Balazs Z, Pfisterer P, Baumgartner L et al. Inhibition of 11[beta]-hydroxysteroid dehydrogenase type 1 by plant extracts used as traditional antidiabetic medicines. Fitoterapia 2009; 80: 200-205.
33. Mishra A, Bhatti R, Singh A, Singh Ishar MP. Ameliorative effect of the cinnamon oil from Cinnamomum zeylanicum upon early stage diabetic nephropathy. Planta Med 2010; 76: 412-417.
34. Rajbir B, Kaur S, Singh J, Ishar MPS. Ameliorative effect of volatile oil from Cinnamomum zeylanicum on hyperalgesia in alloxan diabetic rats. Can J Pure Appl Sci 2009; 3: 887-895.
35. Ranilla LG, Kwon YI, Apostolidis E, Shetty K. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresour Technol 2010; 101: 4676-4689.
36. Roffey B, Atwal A, Kubow S. Cinnamon water extracts increase glucose uptake but inhibit adiponectin secretion in 3T3-L1 adipose cells. Mol Nutr Food Res 2006; 50: 739-745.
37. Shen Y, Fukushima M, Ito Y, Muraki E, Hosono T, Seki T et al. Verification of the antidiabetic effects of cinnamon (Cinnamomum zeylanicum) using insulin-uncontrolled type 1 diabetic rats and cultured adipocytes. Biosci Biotechnol Biochem 2010; 74: 2418-2425.
38. Soonham SY, Samir MK. Effect of cinnamon on plasma glucose concentration and the regulation of 6-phosphofructo-1-kinase activity from the liver and small intestine of streptozotocin induced diabetic rats. J Biolog Sci 2010; 10: 761-766.
39. Subash Babu P, Prabuseenivasan S, Ignacimuthu S. Cinnamaldehyde - a potential antidiabetic agent. Phytomedicine 2007; 14: 15-22.
40. Taher M, Fadzilah AAM, Mohomad RS. A proanthocyanidin from Cinnamomum zeylanicum stimulates phosphorylation of insulin receptor in 3T3-L1 adipocytes. J Teknologi 2006; 44: 53-68.
41. Verspohl EJ, Bauer K, Neddermann E. Antidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum in vivo and in vitro. Phytother Res 2005; 19: 203-206.
42. Zari TA, Al-Logmani AS. Long-term effects of Cinnamomum zeylanicum Blume oil on some physiological parameters in streptozotocin-diabetic and non-diabetic rats. Bol Latinoam Caribe Plantas M 2009; 8: 266-274.
43. Adisakwattana S, Lerdsuwankij O, Poputtachai U, Minipun A, Suparpprom C. Inhibitory activity of cinnamon bark species and their combination effect with acarbose against intestinal α-glucosidase and pancreatic α-amylase. Plant Foods Hum Nutr 2011; 66: 143-148.
44. Kannappan S, Jayaraman T, Rajasekar P, Ravichandran MK, Anuradha CV. Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat. Singapore Med J 2006; 47: 858-863.
45. Shihabudeen MS, Priscilla H, Thirumurugan K. Cinnamon extract inhibits alpha-glucosidase activity and dampens postprandial glucose excursion in diabetic rats. Nutr Metab (Lond) 2011; 8: 46.
46. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008; 22: 659-661.
47. Jayaprakasha JK, Negia PS, Jena BS, Jagan Mohan Rao L. Antioxidant and antimutagenic activities of Cinnamomum zeylanicum fruit extracts. J Food Comp Anal 2007; 20: 330-336.
48. Vats V, Yadav SP, Grover JK. Ethanolic extract of Ocimum sanctum leaves partially attenuates streptozotocin-induced alterations in glycogen content and carbohydrate metabolism in rats. J Ethnopharmacol 2004; 90: 155-160.
49. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007; 132: 2169-2180.
50. Joshi K, Awte S, Bhatnagar P, Walunj S, Gupta R, Joshi S et al. Cinnamomum zeylanicum extract inhibits proinflammatory cytokine TNFμ: in vitro and in vivo studies. Pharmaceut Biotechnol 2010; 2: 14-21.
51. Peng X, Ma J, Chao J, Sun Z, Chang RC, Tse I et al. Beneficial effects of cinnamon proanthocyanidins on the formation of specific advanced glycation endproducts and methylglyoxal-induced impairment on glucose consumption. J Agric Food Chem 2010; 58: 6692-6696.
52. Anderson RA. Chromium and polyphenols from cinnamon improve insulin sensitivity. Proc Nutr Soc 2008; 67: 48-53.
53. Witters LA. The blooming of the French lilac. J Clin Invest 2001; 108: 1105-1107.
54. Modak M, Dixit P, Londhe J, Ghaskadbi S, Paul ADT. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 2007; 40: 163-73.
55. Rudkowska I. Functional foods for health: focus on diabetes. Maturitas 2009; 62: 263-269.
56. Altschuler JA, Casella SJ, MacKenzie TA, Curtis KM. The effect of cinnamon on A1C among adolescents with type 1 diabetes. Diabetes Care 2007; 30: 813-816.
57. Zhang W, Xu YC, Guo FJ, Meng Y, Li ML. Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. Chin Med J (Engl) 2008; 121: 2124-2128.